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While we were isolating Bartonella quintana from body
lice, 40 Acinetobacter baumannii strains were also isolated
and genotyped. One clone was unique and the other was
ampicillin susceptible. A. baumannii DNA was later detect-
ed in 21% of 622 lice collected worldwide. These findings
show an A. baumannii epidemic in human body lice.
T
he body louse has been demonstrated to be the vector
of three human pathogens: Rickettsia prowazekii, the
agent of epidemic typhus; Bartonella quintana, the agent
of trench fever; and Borrelia recurrentis, the agent of
louseborne recurrent fever (1). While trying to isolate
Bartonella quintana from body lice of homeless persons in
Marseille, we isolated six Acinetobacter spp. (2) subse-
quently identified as A. baumannii. They were susceptibile
to ampicillin, whereas Acinetobacter  are almost always
resistant to ampicillin in France (3). We further isolated
other A. baumannii from body lice in Marseille and now
have 40 isolates; 21 are susceptible to ampicillin. To inves-
tigate the possibility of a clonal diffusion in lice, the recA
gene sequence of isolates was determined and compared to
that of the collection and strains. To test if the body
louse–A. baumannii association is observed worldwide,
we investigated the presence of A. baumannii DNA in a
large collection of body lice.
The Study
The 40 body lice–associated A. baumannii were
obtained during studies of homeless shelters in Marseille
(4). The procedure for isolation of these strains has been
detailed previously (2). Provisional identification of iso-
lates was based on Gram stain and results of oxidase test
and API 20NE identification strip (Biomérieux, Marcy
l’Etoile, France). We also tested the 19 strains of A. bau-
mannii available at the CIP (Institut Pasteur, Paris, France)
and 3 clinical strains isolated in our laboratory during the
same period (Table 1). Bacteria were routinely grown at
37°C with 5% CO2 on Columbia sheep blood agar
(Biomerieux). The recAgene amplification was performed
with specific primers rA1 (5′-CCTGAATCTTCTG-
GTAAAAC-3′) and rA2 (5′-GTTTCTGGGCTGCCAAA-
CATTAC-3′), as described previously (5). All sequences
were manually edited, and all ambiguous parts were ampli-
fied and sequenced again. Amplifying the recA gene
allowed unambiguous determination of the sequence of a
336-bp fragment for all isolates. Variation in nucleotides
occurred at 10 positions and determined eight genotypes
(Table 1), which have been deposited in the GenBank data-
base with the following accession no.: 1, AY274826; 2,
AY274827; 3, AY274828; 4, AY274829; 5, AY274830; 6,
AY274831; 7, AY274832; 8, AY274833. The translated
protein sequences were all identical, except for genotype 2,
in which a valine was replaced by an isoleucine at position
68.  recA types 1 and 2 were isolated from body
louse–associated  A. baumannii; for the 21 collection
strains, seven genotypes were observed. Genotype 2 was
unique to body louse–associated A. baumannii. Genotype
1 was associated with susceptibility to ampicillin in body
louse–associated A. baumannii and was common to seven
collection strains. However, all collection strains, whatev-
er the genotype, were resistant to ampicillin, even strains
of the Unité des Rickettsies that have the same geographic
origin as the body louse A. baumannii.
We then tested a large collection of body lice for A.
baumannii DNA. We tested by polymerase chain reaction
(PCR) a collection of 622 body lice sampled in France,
Burundi, Rwanda, Peru, Algeria, Portugal, and the
Netherlands (6). Fifty laboratory lice were used as con-
trols. Detection was performed by amplifying the recA
gene with A. baumannii–specific primers ACI381F (5′-
CACAATGACATTGCAAGCAATTG-3′) and ACI382R
(5′-CCAATTTTCATACGAATCTGG-3′) specifically
designed for this study. These primers were previously
shown not to produce amplicons from A. calcoaceticus,
Acinetobacter  genospecies 3, Acinetobacter genospecies
13, A. haemolyticus, A. johnsonii, or A. lwoffi. As control
for PCR amplification, we used 18Saidg-18Sbi primer
pair, which allows amplification of an 18S rRNA gene
fragment of arthropods. Consensus forward primer
18Saidg (5′-TCTGGTTGATCCTGCCAGTA-3′) was
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Table 1. Types of recA gene sequences
a
Acinetobacter baumannii strains  
(n = 62) 
recA 
type 
Ampicillin 
susceptibility 
Lice associated (n = 21)  1  Yes 
Lice associated (n = 19)  2  No 
CIP 70.34, CIP 70.32, UR 121120, CIP 
70.8, CIP 70.9, CIP 70.33, UR 73415 
1 No 
CIP 54.147, CIP 70.28, CIP 103572, 
UR 37033, CIP 53.77, CIP 70.22, CIP 
105742 
3 No 
CIP 70.24, CIP 68.38  4  No 
CIP 70.10, CIP 70.21  5  No 
CIP 54.97  6  No 
CIP 53.79  7  No 
CIP 64.1  8  No 
aCIP, strains from the Collection de l’Institut Pasteur (Paris, France); UR, 
clinical strains from Unité des Rickettsies. determined after alignment of 18S rRNA sequences of
Drosophila melanogaster (GenBank accession no.
M21017) and Aedes aegypti (GenBank accession no.
M95126). The consensus reverse primer 18Sbi primer was
the one described by DeSalle et al. (7). Atotal of 130 (21%)
body lice were positive for  A. baumannii (Table 2). None
of the 50 laboratory lice was positive. To investigate the
genotype association observed among A. baumannii strains
isolated from Marseille, we sequenced 50 recA amplicons
obtained from the lice of different geographic origins
(Table 2). Genotypes 1 and 2 were the only ones detected in
France; genotype 2 was found in France only. In other parts
of the world, genotypes 1, 3, and 4 were observed, with a
predominance of genotype 1, similar to the findings in
France. Type 4 genotype was the second most common
genotype but was absent in European lice. It seems that
body louse–associated A. baumannii are oligoclonal, and
their distribution is different from that of collection strains.
Even if genotype 1 is the most common in all cases, geno-
types 2 and 4 are overrepresented in body louse–associated
strains. However, contrary to culture after body lice decon-
tamination, we cannot rule out that A. baumannii infection
occurred through external contamination.
Conclusions
The genotype of the 40 A. baumannii from Marseille
from the body lice of homeless persons are limited to two
clones; one is exclusively associated with strains caused by
body lice, and the other is associated with ampicillin sus-
ceptibility in body louse–associated strains. This finding
shows an A. baumannii epidemic in body lice. A. bauman-
nii is mainly implicated in cases of hospital-acquired infec-
tions but has also been reported as a cause of severe
community-acquired infections, including pneumonia,
endocarditis, and meningitis, mostly in persons who are
alcoholics (8). While ingesting only blood from humans,
the louse has a sterile midgut, and the presence of bacteria
is likely caused by the louse’s ingesting contaminated
blood (2). Moreover, previous studies have shown that A.
baumannii is not a common skin-associated Acinetobacter
in Europe, unlike in tropical areas, since it is found on the
skin of <1.5% of healthy persons (9). Our results indicate
that association of A. baumannii with body lice is likely
caused by undiagnosed transient A. baumannii bacteremia
in patients harboring body lice; however, because the fre-
quency of skin association of A. baumannii in the home-
less subpopulation is unknown, contamination from body
lice cannot be ruled out. Relatively low-virulence flora,
such as Staphylococcus epidermidis or diptheroids, may be
destroyed by leukocytes, antibody, and complement in the
blood meal, whereas the more virulent bacteria, such as A.
baumannii, could survive because they resist the defense
mechanism of the blood meal and those of the body lice.
However, we never isolated S. aureus from lice, which is a
virulent bacterium and known to be a common skin com-
mensal agent. From preliminary work, we have observed
that body lice may be infected by several bacterial species
(L. Houamdi, unpub. data) and that the occurrence of body
louse–transmitted disease occurs because causative bacte-
ria (B. quintana, R. prowazekii, and B. recurrentis) induce
relapsing bacteremia rather than specifically adapting to
body lice (10). Finally, if our hypothesis of A. baumannii
bacteremia in patients harboring body lice is true, their
clinical manifestations in homeless persons remain to be
determined.
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